Equibles does not estimate personal net worth.
Get an email with a short summary when Charles River Laboratories International, Inc. publishes a filing, an earnings call transcript or a press release.
Get CRL alertsJames Foster is recorded as Chairman, Board Member and CEO at Charles River Laboratories International, Inc. (CRL). The proxy statement of Charles River Laboratories International, Inc. reports total compensation of $13,473,609 for James Foster in fiscal 2024, including a base salary of $1,512,578. Disclosed compensation is on record for 8 fiscal years. James Foster has spoken on 9 earnings calls across 1 company, most recently for Charles River Laboratories International, Inc. on November 5, 2025. Charles River Laboratories International, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Charles River Laboratories International, Inc. includes Abraham Ceesay (CEO and Board Member), Craig B. Thompson (CEO and Board Member), James C. Foster (CEO and Board Member) and 7 others.
“Before I comment on our third quarter results, I'd like to discuss our strategic review. As you know from today's press release, we provided an update on our comprehensive strategic review.”
“We reported another solid financial performance in the second quarter, meaningfully exceeding our prior outlook due primarily to favorable DSA results.”
“We are pleased to end the year with a fourth-quarter performance that was slightly better than expected, yielding annual revenue and non-GAAP earnings per share higher than the guidance that we issued in November.”
“It’s a little bit imponderable of the election. I think that if it had gone the other way, IRA might have been beefed out, additional drugs might have been added to it in the short term.”
“The stability and resilience of Charles River’s business model were very clear in 2023.”
Diagnostics & Research · Healthcare
Chairman, Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Charles River Laboratories International, Inc. (CRL) | Chair, President, Chief Executive Officer and Director | $1,512,578 | $13,473,609 |
| 2023 | Charles River Laboratories International, Inc. (CRL) | Chair, President, Chief Executive Officer and Director | $1,461,866 | $14,096,924 |
| 2022 | Charles River Laboratories International, Inc. (CRL) | Chair, President, Chief Executive Officer and Director | $1,399,442 | $13,447,872 |
| 2021 | Charles River Laboratories International, Inc. (CRL) | Chair, President, Chief Executive Officer and Director | $1,353,841 | $13,705,581 |
| 2020 | Charles River Laboratories International, Inc. (CRL) | Chairman, President, Chief Executive Officer and Director | $1,354,971 | $13,483,411 |
| 2019 | Charles River Laboratories International, Inc. (CRL) | Chair, President, Chief Executive Officer and Director | $1,272,885 | $17,722,105 |
| 2018 | Charles River Laboratories International, Inc. (CRL) | Chairman, President, Chief Executive Officer and Director | $1,225,473 | $14,450,801 |
| 2017 | Charles River Laboratories International, Inc. (CRL) | Chairman, President, Chief Executive Officer and Director | $1,184,033 | $12,575,597 |
